BBA Presenting on Early Feasibility Studies in the United States

BBA Presenting on Early Feasibility Studies in the United States

Principal Consultant for BBA, Mark Gosnell will present on the Early Feasibility Study (EFS) program where he will review which devices are eligible for the pathway, the approval process and tips for success. This presentation will be given at the Arena Outsourcing in Clinical Trials – March 21-21, in Tel Aviv, Israel.  To view the full program details visit http://www.arena-international.com/octisrael. If you would like more information about work that BBA is currently doing with the FDA in the EFS program, contact us at info@boston-biomedical.com.

Be sure to follow us on twitter at https://twitter.com/BBA_CRO and LinkedIn at https://www.linkedin.com/company-beta/1312584/.

Tags:
,
Mack Rubley
mrubley@boston-biomedical.com

Comments

No Comments

Post A Comment

BBA News and Blog

Want to be updated on the latest news and insights from our team?

You have Successfully Subscribed!

MENU